U.S. Pharmaceuticals
Manufacturer / marketing-authorisation holder
U.S. Pharmaceuticals — 22 products across 1 markets, 11 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
U.S. Pharmaceuticals — 22 productos en 1 mercados, 11 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
U.S. Pharmaceuticals —— 共 22 个产品,覆盖 1 个市场、11 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
22 products · 1 markets · 11 brand names
22 productos · 1 mercados · 11 marcas
22 个产品 · 1 个市场 · 11 个品牌名
Products by country
US
Source: api.fda.gov
| Brand | Active ingredient(s) | Form |
|---|---|---|
| BOSULIF | Bosutinib | tablet |
| Cibinqo | 阿布昔替尼 | tablet |
| Cibinqo | 阿布昔替尼 | tablet |
| Cibinqo | 阿布昔替尼 | tablet |
| Duavee | Bazedoxifene + Estrogens, Conjugated | tablet |
| Elrexfio | Elranatamab | injection |
| INLYTA | 阿昔替尼 | tablet |
| INLYTA | 阿昔替尼 | tablet |
| Ibrance | Palbociclib | tablet |
| Ibrance | Palbociclib | tablet |
| Ibrance | Palbociclib | tablet |
| Litfulo | 甲苯磺酸利特昔替尼 | capsule |
| Lorbrena | Lorlatinib | tablet |
| Talzenna | Talazoparib | capsule |
| Talzenna | Talazoparib | capsule |
| Talzenna | Talazoparib | capsule |
| XELJANZ | 枸橼酸托法替布 | tablet |
| XELJANZ | 枸橼酸托法替布 | liquid |
| XELJANZ | 枸橼酸托法替布 | tablet |
| XELJANZ | 枸橼酸托法替布 | tablet |
| XELJANZ | 枸橼酸托法替布 | tablet |
| ZAVZPRET | Zavegepant | topical |